On Monday, the European Commission proposed to ban two new psychoactive substances (NPS) - cycloproplyfentanyl and methoxyacetylfentanyl - across the European Union.
These strong synthetic opioids can cause severe harm to health, sometimes resulting in death, and pose a growing threat to European citizens, the EC stated.
Commissioner for Migration, Home Affairs and Citizenship Dimitris Avramopoulos said: "We have taken quick and decisive steps to stop illicit drugs from spreading across Europe – in 2017 we have proposed to ban 16 new psychoactive substances and put in place stronger EU-wide rules. Today, we are following up on the efforts to better protect Europeans from dangerous drugs and propose to ban two new, potentially life-threatening, substances. We need to stay vigilant, continue our work and monitor the situation closely - in the coming weeks we will present a report with the main drug use trends in the EU."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze